Farmacia Hospitalaria y Farmacogenómica

Villanueva-Bueno C; Collado-Borrell R; Escudero-Vilaplana V; Revuelta-Herrero JL; Marzal-Alfaro MB; González-Haba E; Arranz-Arija JÁ; Osorio S; Herranz-Alonso A; Sanjurjo-Saez M.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.

Frontiers in Public Health. 2022; 10: 978783-978783 Nº de citas: 4 [doi:10.3389/fpubh.2022.978783]

Mercadal-Orfila G; Lizeaga G; Fernández-Llamazares CM; Tortajada-Goitia B; García Cabrera E; Morillo-Verdugo R; Negro-Vega E.

Outpatient pharmaceutical care satisfaction survey through Telepharmacy during COVID-19 pandemic in Spain.

FARMACIA HOSPITALARIA. 2022; 46(7): 69-85

Villanueva-Bueno C; Collado-Borrell R; Rodríguez-González CG; Escudero-Vilaplana V; Chamorro-de-Vega E; Ais-Larisgoitia A; Herranz-Alonso A; Sanjurjo-Sáez M.

Implementation and evaluation of a home pharmaceutical care model through Telepharmacy.

FARMACIA HOSPITALARIA. 2022; 46(7): 36-46

Morillo-Verdugo R; Collado-Borell R; Arrondo-Velasco A; Domínguez-Cantero M; Fernández-Polo A; González-Corominas E; Gutiérrez E; Linares-Alarcón A; Parro-Martín MLÁ; Rodríguez-Cabezas MÁ; Gomis-Pastor M.

Implementation of pharmaceutical care through Telepharmacy: A guide for professionals and patients.

FARMACIA HOSPITALARIA. 2022; 46(7): 115-122

Bravo-Gomez, A; Salvador-Martin, S; Zapata-Cobo, P; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain

Pharmaceutics. 2022; 14(10): Nº de citas: 11 [doi:10.3390/pharmaceutics14102082]

Chamorro-de-Vega E; Romero-Jiménez R; Escudero-Vilaplana V; Ais-Larisgoitia A; Lobato Matilla ME; González CM; Menchén L; Baniandrés O; Ibares-Frias L; Lobo-Rodríguez C; Herranz-Alonso A; Sanjurjo M.

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

JOURNAL OF MEDICAL INTERNET RESEARCH. 2022; 24(9): Nº de citas: 6 [doi:10.2196/37445]

Butragueno-Laiseca, L; Marco-Arino, N; Troconiz, IF; Grau, S; Campillo, N; Garcia, X; Padilla, B; Fernandez, SN; Slocker, M; Santiago, MJ.

Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy

CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(9): Nº de citas: 9 [doi:10.1016/j.cmi.2022.03.031]

Romero-Jimenez, R; Escudero-Vilaplana, V; Chamorro-de-Vega, E; Ais-Larisgoitia, A; Lobato-Matilla, E; Somoza-Fernandez, B; Ruiz-Briones, P; Gonzalez, C; Baniandres, O; Menchen, L; Lobo-Rodriguez, C; Herranz, A; Sanjurjo, M.

Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare

Frontiers in Immunology. 2022; 13: Nº de citas: 4 [doi:10.3389/fimmu.2022.915578]

Escudero-Vilaplana, V; Romero-Medrano, L; Villanueva-Bueno, C; de Diago, MR; Yanez-Montesdeoca, A; Collado-Borrell, R; Campana-Montes, JJ; Marzal-Alfaro, B; Revuelta-Herrero, JL; Calles, A; Galera, M; Alvarez, R; Herranz, A; Sanjurjo, M; Artes-Rodriguez, A.

Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App

Frontiers in Oncology. 2022; 12: [doi:10.3389/fonc.2022.880430]

Vicente-Valor, J; Escudero-Vilaplana, V; Collado-Borrell, R; Lopez-Lopez, C; Villanueva-Bueno, C; Revuelta-Herrero, JL; Ruiz-Briones, P; Somoza-Fernandez, B; Herranz, A; Sanjurjo, M.

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022; 28(5): 1259-1263 Nº de citas: 5 [doi:10.1177/10781552221074621]

Garcia-Sanchez, S; Collado-Borrell, R; Gonzalez-Haba, E; Revuelta-Herrero, JL; Escudero-Vilaplana, V; Marzal-Alfaro, MB; Sanchez-Fresneda, MN; Mur-Mur, A; Herranz, A; Martin, M; Sanjurjo, M.

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Frontiers in Oncology. 2022; 12: Nº de citas: 5 [doi:10.3389/fonc.2022.889575]

Olmedo, M; Kestler, M; Valerio, M; Padilla, B; Rodríguez González C; Chamarro E; Machado, M; Alvarez-Uria, A; Alcala, L; Muñoz P; Bouza, E.

Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

Revista Espanola de Quimioterapia. 2022; 35(3): 279-283 Nº de citas: 7 [doi:10.37201/req/120.2021]

Escudero-Vilaplana, V; Bernal, E; Casado, G; Collado-Borrell, R; Diez-Fernandez, R; Roman, ABF; Folguera, C; Gonzalez-Cortijo, L; Herrero-Fernandez, M; Marquina, G; Nieto, CM; Rodriguez, MA; Rubio, AR; Sanmartin-Fenollera, P; Castillo, MJV; Comellas, M; Guerra, EM.

Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer

Frontiers in Oncology. 2022; 12: Nº de citas: 9 [doi:10.3389/fonc.2022.885910]

Villanueva-Bueno, C; Collado-Borrell, R; Revuelta-Herrero, JL; Fernandez-Roman, AB; Casado-Abad, G; Escudero-Vilaplana, V.

Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol

FARMACIA HOSPITALARIA. 2022; 46(4): 265-269 Nº de citas: 1 [doi:10.7399/fh.11835]

Moreno-Martinez, E; de la Serna-Torroba, J; Escudero-Vilaplana, V; Hernandez-Rivas, JA; Sanchez-Cuervos, M; Sanchez-Hernandez, R.

Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain

FARMACIA HOSPITALARIA. 2022; 46(3): 121-132 [doi:10.7399/fh.11829]

Collado-Borrell, R; Escudero-Vilaplana, V; Narrillos-Moraza, A; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.

Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes

FARMACIA HOSPITALARIA. 2022; 46(3): 173-181 Nº de citas: 16 [doi:10.7399/fh.11830]

Garcia-Sanchez, S; Somoza-Fernadez, B; de Lorenzo-Pinto, A; Ortega-Navarro, C; Herranz-Alonso, A; Sanjurjo, M.

Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

JMIR mHealth and uHealth. 2022; 10(4): Nº de citas: 8 [doi:10.2196/29985]

Martinez-Barrio, J; Lopez, JAM; Galindo, M; Ais, A; Sanchez, NM; Cano, L.

Importance of family planning in patients with immune-mediated inflammatory diseases: A multidisciplinary approach

Reumatologia Clinica. 2022; 18(4): 200-206 [doi:10.1016/j.reuma.2020.11.007]